Log In
Print this Print this

brodalumab (Lumicef) (KHK4827) (formerly AMG 827)

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionHuman IgG2 mAb against IL-17 receptor (IL17R; IL17RA)
Molecular Target Interleukin-17 (IL-17) receptor (IL17R) (IL17RA)
Mechanism of ActionAntibody; Interleukin-17 (IL-17) receptor agonist
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today